Clinical trial registry record

EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registry ID
NCT01808690
Last registry update
September 30, 2021
Status
Completed
Phase
PHASE3
Sponsor
University of Colorado, Denver
Enrollment
52
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Metformin · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 50%. These are automated routing signals, not medical or evidence-strength ratings.